|
|
|
|
|
|
Sponsors and Collaborators: |
Dana-Farber Cancer Institute University of Massachusetts |
Information provided by: | Dana-Farber Cancer Institute |
ClinicalTrials.gov Identifier: | NCT00165282 |
The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.
Condition | Intervention | Phase |
Hematologic Malignancy Bone Marrow Transplantation Stem Cell Transplantation |
Behavioral: Mindfulness Meditation Behavioral: Standard of Care Behavioral: Nurse Education |
Phase II |
MedlinePlus related topics: | Bone Marrow Transplantation Cancer |
Study Type: | Interventional |
Study Design: | Other, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Mindfulness Meditation in Bone Marrow Transplantation |
Estimated Enrollment: | 280 |
Study Start Date: | April 2005 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
Group 1: Active Comparator
Normal standard of care
|
Behavioral: Standard of Care
Standard care given during BMT
|
Group 2: Active Comparator
Meets with oncology nurse
|
Behavioral: Nurse Education
Meets with oncology nurse to have questions answered about stem cell/BMT experience
|
Group 3: Active Comparator
Taught Mindfulness meditation
|
Behavioral: Mindfulness Meditation
Taught mindfulness meditation by mindfulness instructor and audio c/d
|
Patients will be assigned to one of three study groups:
Mindfulness meditation is a technique that may help in coping with the stress and difficulties associated with cancer and undergoing a stem cell/bone marrow transplant. It involves learning to be in the present moment by paying attention to your breathing, sights, and sounds, and to sensations you may be experiencing, or thoughts and feelings you may be having.
Mindfulness meditation has been shown to be helpful to patients in the clinic who have cancer and other medical conditions.
Patients, regardless of random group assignment, will complete a questionnaire 8 different times, from before they are admitted to the hospital until 6 months after discharge.
Patients will also provide two urine samples while in the hospital to measure the levels of stress hormones present in the urine.
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Susan Bauer-Wu, D.N.Sc. | 617-632-1925 | susan_bauer_wu@dfci.harvard.edu |
United States, Georgia | |||||
Emory University | Recruiting | ||||
Atlanta, Georgia, United States | |||||
United States, Massachusetts | |||||
Dana-Farber Cancer Institute | Recruiting | ||||
Boston, Massachusetts, United States, 02115 | |||||
Contact: Martha W. Healey, RN, FNP mhealey1@partners.org | |||||
University of Massachusetts Medical School | Recruiting | ||||
Worcester, Massachusetts, United States, 01655 | |||||
Contact: James Carmody 508-856-1205 |
Dana-Farber Cancer Institute |
University of Massachusetts |
Principal Investigator: | Susan Bauer-Wu, D.N.Sc. | Dana-Farber Cancer Institute |
Responsible Party: | Dana-Farber Cancer Institute ( Mary Cooley, PhD, RN ) |
Study ID Numbers: | 05-070 |
First Received: | September 9, 2005 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00165282 |
Health Authority: | United States: Institutional Review Board |
|
|
|